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Budd-Chiari Syndrome is a pathology of the liver caused by obstruction of the hepatic veins.
This disease is rare in the USA and more common in Asia, which is a good reason to
misdiagnose and unable to provide adequate and timely treatment to such patients. Delay in
making a diagnosis of such a disease might lead to complications and cost the life of the patient.
In this paper, the definition, etiology, clinical manifestation, laboratory values, method of
diagnosis, treatment and follow-up methods of the disease are included.

Introduction
Budd-Chiari Syndrome is a disease manifested by occlusion of the hepatic vein/s, which is
presented with rapidly progressive abdominal pain, enlarged liver, ascites, and abnormal liver
function. Thrombosis, stenosis, or membranous web blockages can occur in these areas inhibiting
hepatic blood flow (6). When hepatic venous obstruction causes a prolonged increase in pressure
within the anastomoses, the veins can become enlarged (2). There are two classifications of BuddChiari syndrome. Primary is a congenital obstruction of the hepatic veins. Secondary is related to
the invasion of the IVC and hepatic veins by hepatocellular carcinoma, abscess, cysts, etc. (16).
Ultrasound, paired with color Doppler, is the first-choice imaging modality for Budd-Chiari
syndrome because of its specificity, sensitivity and lack of harmful ionizing radiation.
Young adult women on birth control pills who later develop the classic symptoms of the illness
are the typical patients in North America. The syndrome is more common in India, South Africa,
and the Orient (20). When Budd-Chiari Syndrome is suspected, liver enzyme levels and other
organ markers such as creatinine, urea, electrolytes, and lactate dehydrogenase (LDH) should be
tested. Ultrasound study of the abdomen/liver is a useful tool to diagnose this syndrome. Other
invasive tests such as retrograde angiography and liver biopsy are sometimes essential for
differential diagnosis purpose. The occlusion of hepatic veins can happen due to venous blood
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clot (thrombosis) (Figure 1) and compression of the hepatic vein/s by tumors. The venous
thrombosis is treated with anticoagulant medication and compression is relieved with surgical
procedures. Some patients develop Budd-Chiari Syndrome as a complication of Polycythemia
Vera (16).

Figure 1. Visualization of the left hepatic vein stenosis and
occlusion with right hepatic vein plaque build-up.

Etiology
The common causes of Budd-Chiari syndrome are congenital abnormalities, coagulation
abnormalities, pregnancy, prolonged oral contraceptive use, tumor extension, infection,
malnutrition, and trauma (6) (12). Myeloproliferative disease, Behcet disease, antiphospholipid
antibodies syndrome, protein S deficiency, thrombocythemia, celiac disease, hepatocellular
carcinoma, Gravitz tumor, and previous liver resection are considered to be prothrombic factors
and conditions attributing to the diagnosis of Budd-Chiari Syndrome.
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Figure 2. Normal, hepatofugal blood flow.

Clinical findings
Patients’ clinical findings depends on the location of the obstruction and whether it is classified as
primary or secondary Budd-Chiari Syndrome. Clinical presentation ranges from asymptomatic
thrombosis to liver failure from liver congestion (7). In order the syndrome to be clinically
manifested, at least two of the hepatic veins must be blocked. Signs and symptoms are right-upper
abdominal pain, high blood pressure, jaundice, hepatomegaly, and/or splenomegaly, and ascites
(18).

Diagnosis
Diagnostic methods include Ultrasound, Magnetic Resonance imaging (MRI), Computed
Tomographic Imaging (CT), Liver Function Tests (LFT), and liver biopsy. Ultrasound provides the
ability to diagnose as well as monitor progression and severity of the disease. It also helps to find
out the underlying pathology, determine the velocity of blood flow using spectral Doppler, explore
individualized treatment options, and provide post-diagnosis and treatment follow-ups (7).
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Ultrasound has played a major role in improving patients’ life expectancy with Budd-Chiari
syndrome; from nearly always fatal, in the 1980s, to a 90% five-year survival rate in 2019 (3).

Sonographic Evaluation
Diagnostic ultrasound is crucial in determining the diagnosis and best treatment options for each
distinct patient. Imaging techniques may reveal findings of Budd-Chiari syndrome including:
dilated veins with absent, inverted, or turbulent blood flow, large intrahepatic or subcapsular
venous collaterals, spider-web appearance in vein openings, hypoechoic fibrous cords in place of
normal veins, and/or an absent or flat venous wave-forms. Indirect sonographic findings of BuddChiari syndrome include: enlarged caudate lobe and atrophy of the affected liver segments. The
liver may appear hypoechoic in early stages of thrombosis and progresses to appear hyperechoic
and heterogeneous in later stages (6).

Figure 4. Normal, phasic blood flow in the right hepatic vein.

Hepatic Venous Blood Flow Analysis
Sonographic color Doppler evaluation is used to visualize stenosis, complete occlusion,
anastomoses, reversal of blood flow, and changes in velocity of blood flow. Doppler signals change
from normal hepatofugal (Figure 2) and phasic flow (Figure 4) to either absent, reversed, turbulent,
or continuous flow (6). The flow will be absent if the hepatic vein becomes completely occluded
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(Figure 3). Reversal of flow occurs due to hepatic hypertension from hepatic congestion of the
irregularly shaped hepatic veins (sinusoids) (Figure 5). Turbulent flow can occur directly after
areas of stenosis due to the change in pressure and velocity within the vessel. In areas of stenosis,
blood flow velocity increases.

Figure 5. Retrofugal blood flow in the right hepatic vein from
flow reversal. Compare to normal flow (Figure 3).

Treatment
Treatment of Budd-Chiari disorder includes a multitude of different options based on the severity
and findings of the disease. The primary medical management is anticoagulation therapy to prevent
further venous thrombosis, and to prevent portal hypertension, ascites, and other complications
(2). Endovascular treatment is used to relieve hepatic congestion and restore hepatocyte perfusion.
Surgical methods include resection of membranes with or without inferior vena cava
reconstruction, shunts, and liver transplants (2). The Transjagular intrahepatic portosystemic shunt
(TIPS) is placed to redirect blood flow. Liver transplantation may be performed as a last resort if
the other treatment options don’t work. Liver transplant results in a 95% ten-years survival rate
(13). Once the treatment initiated, patients have to be monitored closely to follow-up the patency
of the TIPS, monitoring the liver function test, and to follow the blood coagulability. If significant
stenosis is noticed during the follow-ups of the patients with TIPS, revision of the TIPS will be
performed.

decompensated cirrhosis
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Conclusion
Budd-Chiari Syndrome is a rare disorder characterized by right-upper quadrant abdominal pain,
hepatomegaly, and ascites. Although lab works, CT, MRI, and biopsy are essential diagnostic
tools to diagnose this disease, ultrasonography is a non-invasive technique that provides valuable
information and the best tool for diagnosis as well as for follow-up. The mortality rate of patients
with hepatic vein thrombosis is high, but with the routine use of ultrasound imaging, this
syndrome can be diagnosed more often in its milder forms and can be treated early. If the
patients are not treated as early as possible, the prognosis is poor and death can occur within few
months to three years from the time of diagnosis (17).
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